Effects of trazodone on behavioral and physiological signs of stress in dogs during veterinary visits: a randomized double-blind placebo-controlled crossover clinical trial

Sun-A Kim Clinical Animal Behavior Service, Veterinary Medical Teaching Hospital, Chungbuk National University, Cheongju, Korea

Search for other papers by Sun-A Kim in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Michelle R. Borchardt William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA

Search for other papers by Michelle R. Borchardt in
Current site
Google Scholar
PubMed
Close
 RVT
,
Kyuyoung Lee Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA

Search for other papers by Kyuyoung Lee in
Current site
Google Scholar
PubMed
Close
 DVM, MPVM, PhD
,
Elizabeth A. Stelow William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA

Search for other papers by Elizabeth A. Stelow in
Current site
Google Scholar
PubMed
Close
 DVM, DACVB
, and
Melissa J. Bain Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA

Search for other papers by Melissa J. Bain in
Current site
Google Scholar
PubMed
Close
 DVM, DACVB, MS, DACAW

Click on author name to view affiliation information

Abstract

OBJECTIVE

To determine whether a single dose of trazodone administered to dogs before a veterinary visit reduced their behavioral and physiologic signs of stress and owners’ stress during veterinary visits.

SAMPLE

20 dogs and their owners.

PROCEDURES

In this randomized double-blinded placebo-controlled crossover clinical trial, dogs with a history of anxiety during veterinary visits were scheduled for 2 veterinary visits 1 week apart and randomly assigned to receive a single oral dose of either trazodone (9 to 12 mg/kg) or a placebo 90 minutes before transport to the veterinary clinic for alternate visits between September 21 and November 3, 2019. For each visit, we collected and assessed owner-completed surveys of dog stress score (DSS) and owner stress score; various investigator-reported scores, including from video-recorded behavior analyses; and patient-related physiologic data.

RESULTS

Dogs treated with trazodone versus placebo had lower mean DSSs, assessed by owners for physical examination and assessed by video analysis for time spent in the examination room; lower mean SD of normal-to-normal intervals, root mean square of successive heartbeat interval difference, and respiratory rate; and higher mean heart rate. No meaningful differences were observed in other behavioral or physiologic outcomes, including serum cortisol concentrations.

CLINICAL RELEVANCE

A single dose of trazodone before transport reduced signs of stress during veterinary visits for dogs in the present study and may be useful as an anti-anxiety medication for similarly affected dogs, potentially resulting in higher-quality clinical examinations and improved patient welfare.

Abstract

OBJECTIVE

To determine whether a single dose of trazodone administered to dogs before a veterinary visit reduced their behavioral and physiologic signs of stress and owners’ stress during veterinary visits.

SAMPLE

20 dogs and their owners.

PROCEDURES

In this randomized double-blinded placebo-controlled crossover clinical trial, dogs with a history of anxiety during veterinary visits were scheduled for 2 veterinary visits 1 week apart and randomly assigned to receive a single oral dose of either trazodone (9 to 12 mg/kg) or a placebo 90 minutes before transport to the veterinary clinic for alternate visits between September 21 and November 3, 2019. For each visit, we collected and assessed owner-completed surveys of dog stress score (DSS) and owner stress score; various investigator-reported scores, including from video-recorded behavior analyses; and patient-related physiologic data.

RESULTS

Dogs treated with trazodone versus placebo had lower mean DSSs, assessed by owners for physical examination and assessed by video analysis for time spent in the examination room; lower mean SD of normal-to-normal intervals, root mean square of successive heartbeat interval difference, and respiratory rate; and higher mean heart rate. No meaningful differences were observed in other behavioral or physiologic outcomes, including serum cortisol concentrations.

CLINICAL RELEVANCE

A single dose of trazodone before transport reduced signs of stress during veterinary visits for dogs in the present study and may be useful as an anti-anxiety medication for similarly affected dogs, potentially resulting in higher-quality clinical examinations and improved patient welfare.

Supplementary Materials

    • Supplementary Appendix S1 (PDF 115 KB)
    • Supplementary Appendix S2 (PDF 140 KB)
    • Supplementary Appendix S3 (PDF 76 KB)
    • Supplementary Appendix S4 (PDF 179 KB)
All Time Past Year Past 30 Days
Abstract Views 5449 0 0
Full Text Views 4777 2866 313
PDF Downloads 4749 2323 155
Advertisement